The 12-month ASHP-accredited oncology pharmacy residency at the University of Colorado Skaggs School of Pharmacy prepares residents for high levels of success.
As a post graduate year 2 (PGY2) program, completion of a PGY1 program is a required prerequisite, consistent with ASHP accreditation.
As part of this program, our residents receive comprehensive experiences in contemporary oncology practice. Residents provide pharmaceutical care to medical oncology patients in both the inpatient and outpatient oncology settings at the University of Colorado Hospital and the University of Colorado Cancer Center. Clinical rotations include stem cell transplant, medical oncology, pediatric oncology, radiation oncology, developmental therapeutics, supportive care and elective experiences. The residency provides experiences and flexibility to satisfy the specific interests of the resident.
Our residents are directed in skills critical to patient care and effective communication through clinical rotations and structured educational sessions. A multidisciplinary approach to patient care is highly emphasized. Residents will also be involved in the education of pharmacy students, through limited didactic teaching and clerkship precepting of pharmacy students, as well as medical residents and other healthcare professionals. This residency requires the development and implementation of a research project and will give the resident writing experience. Oncology preceptors include several experienced clinical practitioners with opportunities to work with research-oriented faculty members.
Upon successful completion of the residency, residents will be able to pursue positions in academics as well as a variety of clinical practice settings.
Stephanie Giangiuli grew up in New Market, Maryland. She began at Mercer University in Georgia where she played D1 soccer and received her Bachelor’s degree in Biology and minored in Chemistry and Spanish. After completing her Doctor of Pharmacy at the University of Colorado Skaggs School of Pharmacy she went on to do her PGY1 at the University of Washington Medical Center in Seattle, WA. She is excited to come back to CU for her PGY2 in Oncology and is looking forward to teaching some of the classes that inspired her to pursue oncology. Her current clinical interests include solid tumors, clinical research, and side effect management. Following PGY2 residency, Stephanie hopes to pursue a career in ambulatory oncology and research. When not at work, Stephanie can be found hiking, biking, skiing, traveling, and playing soccer.
Kelsey Noetzelmann grew up in various cities throughout the state of Arizona, where she went to Toni & Guy Academy and enjoyed styling hair and specializing in color for a few years prior to exploring her interests in pharmacy. Hawai‘i has been her home for the past eight years while she completed her Doctor of Pharmacy studies at the Daniel K. Inouye College of Pharmacy on the Big Island and her PGY1 residency training at Tripler Army Medical Center on Oahu. She is excited to pursue her passion for oncology by continuing her training as a PGY2 oncology resident at the University of Colorado Anschutz Medical Campus. She fell in love with ambulatory oncology and solid tumors during her student and PGY1 electives, however, she is enthusiastic about exploring the various subspecialties over the next year. Once acclimated, Kelsey hopes to enjoy various adventures such as hiking, camping and is eager to shake the dust off her snowboard and get back out on the slopes!
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
First Floor Room 1223
Aurora, CO 80045
Practice site: University of Colorado Cancer Center (UCCC), Anschutz Outpatient Cancer Pavilion. The UCCC is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Rocky Mountain Region.
Services provided include provision of drug information and education, supportive care management for patients, drug counseling on chemotherapy and investigational agents, toxicity monitoring for patients on phase 1 clinical trials and pharmacy-based chemotherapy-induced anemia clinic.
This is also a rotation site for fourth-year pharmacy students, Pharmacy Practice and Oncology Pharmacy Practice residents.
Clinical research: Serve as Principal Investigator and Co-principal Investigator on Phase 1 and Organ Dysfunction Oncology Clinical Trials.
Areas of interest: Oncology developmental therapeutics, Organ dysfunction, biological correlates associated with molecular targeted agents, chemotherapy dose modification and pharmacy-managed supportive care issues in cancer treatment.